Anti-IL-23a Antibody (Tildrakizumab)
Catalog No.
F1295
Anti-IL-23a Antibody (Tildrakizumab)
Featured Products
Tildrakizumab (SCH 900222) is a humanized anti-IL-23 (p19 subunit) monoclonal antibody. IL-23 is a key cytokine that maintains the Th17 cell phenotype. Tildrakizumab has high affinity for single-chain IL-23 (Kd: 136 pM). Tildrakizumab is effective in moderate to severe plaque psoriasis.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.44 kDa
Dry ice
1326244-10-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Ilumya, tildrakizumab, MK-3222
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NPF7
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
IL-23a
Please avoid freeze-thaw cycles.